Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular vs. Intravenous Tranexamic Acid for Total Hip Arthroplasty
NCT07817537Phase 1Recruiting
- Sponsor
- Alexandria University
- Start
- Jan 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Phase 1, randomised trial of tranexamic acid in hemorrhage (2 arms), sponsored by Alexandria University. Primary endpoint: Change of Hemoglobin Concentration. Started Jan 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT07817537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07817537.